Select Medical Holdings Corp. (NYSE:SEM)’s share price shot up 14.1% on Friday . The company traded as high as $12.50 and last traded at $12.32, with a volume of 748,073 shares traded. The stock had previously closed at $10.80.

A number of research firms have recently weighed in on SEM. Zacks Investment Research downgraded shares of Select Medical Holdings Corp. from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 27th. Robert W. Baird reaffirmed a “hold” rating on shares of Select Medical Holdings Corp. in a research note on Monday, May 16th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $14.00.

The company has a 50-day moving average of $11.19 and a 200-day moving average of $11.19. The firm has a market cap of $1.61 billion and a PE ratio of 10.75.

Select Medical Holdings Corp. (NYSE:SEM) last released its earnings results on Thursday, August 4th. The company reported $0.23 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.24 by $0.01. During the same period in the previous year, the business posted $0.28 EPS. The business earned $1.10 billion during the quarter, compared to analysts’ expectations of $1.10 billion. The company’s quarterly revenue was up 23.7% on a year-over-year basis. On average, analysts anticipate that Select Medical Holdings Corp. will post $0.85 EPS for the current fiscal year.

In other news, Director James E. Dalton, Jr. sold 12,000 shares of the stock in a transaction dated Monday, May 23rd. The shares were sold at an average price of $12.37, for a total transaction of $148,440.00. Following the completion of the transaction, the director now directly owns 95,979 shares in the company, valued at approximately $1,187,260.23. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Several institutional investors have bought and sold shares of the company. New York State Common Retirement Fund increased its position in Select Medical Holdings Corp. by 4.7% in the fourth quarter. New York State Common Retirement Fund now owns 100,400 shares of the company’s stock worth $1,196,000 after buying an additional 4,500 shares in the last quarter. Rhumbline Advisers increased its position in Select Medical Holdings Corp. by 9.3% in the fourth quarter. Rhumbline Advisers now owns 121,833 shares of the company’s stock worth $1,451,000 after buying an additional 10,360 shares in the last quarter. First Trust Advisors LP increased its position in Select Medical Holdings Corp. by 12.9% in the fourth quarter. First Trust Advisors LP now owns 139,474 shares of the company’s stock worth $1,661,000 after buying an additional 15,887 shares in the last quarter. Royce & Associates LLC increased its position in Select Medical Holdings Corp. by 15.9% in the fourth quarter. Royce & Associates LLC now owns 190,000 shares of the company’s stock worth $2,263,000 after buying an additional 26,000 shares in the last quarter. Finally, Wells Fargo & Company MN increased its position in Select Medical Holdings Corp. by 48.5% in the fourth quarter. Wells Fargo & Company MN now owns 1,485,445 shares of the company’s stock worth $17,692,000 after buying an additional 485,013 shares in the last quarter.

Select Medical Holdings Corporation is an operator of specialty hospitals and outpatient rehabilitation clinics. The Company, through its contract therapy business, provides medical rehabilitation services on a contracted basis to nursing homes, hospitals, assisted living and senior care centers, schools and work sites.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.